DRUG:AU:AU-BetaShares Global Healthcare Currency Hedged (AUD)

ETF | Others |

Last Closing

USD 8.86

Change

0.00 (0.00)%

Market Cap

USD 0.17B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

Largest Industry Peers for Others

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.87% 65% D 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.87% 65% D 57% F
Trailing 12 Months  
Capital Gain 13.88% 47% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.88% 47% F 55% F
Trailing 5 Years  
Capital Gain 50.17% 84% B 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 50.17% 84% B 61% D-
Average Annual (5 Year Horizon)  
Capital Gain 6.95% N/A N/A 58% F
Dividend Return 8.50% N/A N/A 57% F
Total Return 1.56% N/A N/A 31% F
Risk Return Profile  
Volatility (Standard Deviation) 8.39% N/A N/A 93% A
Risk Adjusted Return 101.31% N/A N/A 98% N/A
Market Capitalization 0.17B 34% F 66% D+

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.